CVS Caremark Reaches New 52-Week High at $79.50 (CVS)
CVS Caremark (NYSE:CVS) shares hit a new 52-week high during mid-day trading on Friday , Analyst Ratings News reports. The company traded as high as $79.50 and last traded at $78.82, with a volume of 1,784,287 shares. The stock had previously closed at $79.30.
CVS has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark in a research note on Tuesday. They now have a $82.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of CVS Caremark in a research note on Wednesday, August 6th. They now have a $91.00 price target on the stock, up previously from $82.00. Finally, analysts at Cantor Fitzgerald raised their price target on shares of CVS Caremark from $66.00 to $71.00 in a research note on Wednesday, August 6th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $78.90.
The stock’s 50-day moving average is $77.23 and its 200-day moving average is $74.58. The company has a market cap of $91.408 billion and a P/E ratio of 19.44.
CVS Caremark (NYSE:CVS) last announced its earnings results on Tuesday, August 5th. The company reported $1.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter last year, the company posted $0.97 earnings per share. CVS Caremark’s revenue was up 10.7% compared to the same quarter last year. On average, analysts predict that CVS Caremark will post $4.49 earnings per share for the current fiscal year.
In other CVS Caremark news, EVP J. David Joyner unloaded 123,516 shares of the company’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $76.10, for a total transaction of $9,399,567.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.